The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 37,200 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 25,147 | 408,562 | SH | SOLE | 408,562 | 0 | 0 | ||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 27,373 | 3,100,000 | SH | SOLE | 3,100,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 19,923 | 1,647,870 | SH | SOLE | 1,647,870 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 37,928 | 4,420,516 | SH | SOLE | 4,420,516 | 0 | 0 | ||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 4,298 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 24,503 | 1,993,746 | SH | SOLE | 1,993,746 | 0 | 0 | ||
| ENTASIS THERAPEUTICS HLDGS I | COM | 293614103 | 23,738 | 2,181,843 | SH | SOLE | 2,181,843 | 0 | 0 | ||
| GALAPAGOS NV | SPON ADR | 36315X101 | 9,835 | 87,481 | SH | SOLE | 87,481 | 0 | 0 | ||
| GLAUKOS CORP | COM | 377322102 | 39,116 | 602,709 | SH | SOLE | 602,709 | 0 | 0 | ||
| INOGEN INC | COM | 45780L104 | 866,460 | 3,549,320 | SH | SOLE | 3,549,320 | 0 | 0 | ||
| INVUITY INC | COM NEW | 46187J205 | 8,953 | 1,209,854 | SH | SOLE | 1,209,854 | 0 | 0 | ||
| MENLO THERAPEUTICS INC | COM | 586858102 | 14,148 | 1,436,313 | SH | SOLE | 1,436,313 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 21,769 | 1,102,795 | SH | SOLE | 1,102,795 | 0 | 0 | ||
| NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 12,700 | 4,703,720 | SH | SOLE | 4,703,720 | 0 | 0 | ||
| NEURONETICS INC | COM | 64131A105 | 16,832 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
| ORTHOPEDIATRICS CORP | COM | 68752L100 | 23,983 | 654,549 | SH | SOLE | 654,549 | 0 | 0 | ||
| RA PHARMACEUTICALS INC | COM | 74933V108 | 4,070 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| SEASPINE HLDGS CORP | COM | 81255T108 | 15,296 | 983,037 | SH | SOLE | 983,037 | 0 | 0 | ||
| UNUM THERAPEUTICS INC | COM | 903214104 | 6,851 | 665,181 | SH | SOLE | 665,181 | 0 | 0 | ||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 9,267 | 740,740 | SH | SOLE | 740,740 | 0 | 0 | ||
| WRIGHT MED GROUP N V | RIGHT 03/01/2019 | N96617126 | 6,471 | 4,622,032 | PRN | SOLE | 0 | 0 | 4,622,032 | ||